Post‐Microbial Therapeutics for the Next Generation of Medicine
MicrobiologyOpen · 2026-10 · 15 (5)
DOI: 10.1002/mbo3.70427 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MicrobiologyOpen, online erschienen am 30.09.2026. Verfasst von Mohammad Nazrul Islam Bhuiyan und 1 weiteren Autor:innen. Beteiligte Einrichtung: BCSIR Chattogram Laboratories, BCSIR, Chattogram, Bangladesh. Hauptthemen laut MEDLINE: Bacteriophages, Bacteria, Bacterial Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Post‐microbial therapeutics is proposed here as an integrative, function‐centered framework rather than a new therapeutic class. It asks whether a defined microbial perturbation can produce a reproducible change in a microbial function, biochemical output, and clinically relevant host phenotype. Bacteriophages provide a perturbation model because their host dependence permits strain‐selective intervention, but the framework also distinguishes between whole phages and engineered phages, lysins, depolymerases, delivery systems, and combination products. A central requirement is that a microbial module must be defined by experimentally testable functional contribution rather than by statistical co‐occurrence alone. Computationally inferred modules are therefore treated as hypotheses until supported by perturbation, reconstruction, removal/add‐back, flux, or rescue experiments. Evidence reviewed across infection, gastrointestinal, biofilm, and cardiometabolic contexts shows a recurring pattern: phage exposure can alter bacterial abundance, resistance phenotypes, community interactions, and metabolism, but the strength of evidence diminishes as claims shift from bacterial killing to ecosystem restoration and host benefit. Engineering and delivery technologies can improve targeting or exposure, yet they introduce additional constraints in genetic stability, resistance, formulation, pharmacology, and regulation. The framework is consequently best viewed as a testable translational architecture that connects intervention to function and outcome while separating established evidence from emerging hypotheses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BCSIR Chattogram Laboratories, BCSIR, Chattogram, Bangladesh.
- Bangladesh Council of Scientific and Industrial Research (BCSIR), Institute of Food Science and Technology, Dhaka, Bangladesh.
- Bangladesh Council of Scientific and Industrial Research (BCSIR), Biomedical and Toxicological Research Institute (BTRI), Dhaka, Bangladesh.
ORCID-Profile: Mohammad Nazrul Islam Bhuiyan, Maliha Momtaj
Zitieren
APA
Bhuiyan, M. N. I., & Momtaj, M. (2026). Post‐Microbial Therapeutics for the Next Generation of Medicine. MicrobiologyOpen, 15(5). https://doi.org/10.1002/mbo3.70427
Vancouver
Bhuiyan MNI, Momtaj M. Post‐Microbial Therapeutics for the Next Generation of Medicine. MicrobiologyOpen. 2026;15(5). doi:10.1002/mbo3.70427
BibTeX
@article{Bhuiyan2026,
author = {Bhuiyan, Mohammad Nazrul Islam and Momtaj, Maliha},
title = {Post‐Microbial Therapeutics for the Next Generation of Medicine},
journal = {MicrobiologyOpen},
year = {2026},
volume = {15},
number = {5},
doi = {10.1002/mbo3.70427}
}
EUVIMED